Mary Pilon, reporting for the New York Times:
Because Drug Free Sport is paid millions by the N.C.A.A. to administer the program and shares its roots with the organization, critics have argued that the relationship has conflicts of interest.
“You look at the money involved in collegiate sports and the potential earnings out there, then think about the availability of these drugs, and it’s of great concern,” said Charles Yesalis, a professor emeritus of health policy and administration at Penn State. “There are significant loopholes.”